Dr. Ogier is a postdoctoral research fellow at the University of Melbourne, with a research focus on fundamental molecular biology in the inner ear.

Dr. Ogier completed her PhD at the Murdoch Children’s Research Institute in 2020, having identified a novel molecular target for preventing aminoglycoside-induced hearing damage. Following her PhD, she trained at the Sunnybrook Research Institute in Toronto, where she optimised human cochlea cultures for single-cell sequencing and completed further ototoxicity-based research that earned the University of Toronto Witterick Research Prize. Dr. Ogier is now using human stem-cell-derived organoids and state-of-the-art proteomics to better understand how cells in the ear develop, communicate, and die. This research aims to improve our understanding of fundamental biological processes, such as inflammation, fibrotic tissue responses, and sensory cell death in the ear, while simultaneously advancing novel therapeutic approaches to improve hearing outcomes in cochlear implant recipients.